Meta Pixel

News and Announcements

Catcha Group Announces Company’s First Ever Wild Digital Event in Australia

  • Published February 24, 2017 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Catcha Group’s Co-Founder and Group CEO, Patrick Grove, is excited to announce that in less than a month he will be touching down in Sydney for the company’s first ever Wild Digital Event in Australia. Wild Digital Australia is shaping up to be an amazing event, with a great speaker line-up and exciting main stage programs. The tickets are limited- and you don’t want to miss out on this exclusive opportunity!

See February’s Bulletin for the Speaker Lineup for Wild Digital Australia.

KEY TAKEAWAYS:

  • FDV URGES PUSH AT ASIAN FRONTIERS- Article by the Australia.

“… Today Di Gregorio is piloting the strategy of FDV, a business backed by BRW Rich Lister Patrick Grove’s Catcha Group, focused on investing in and providing support to companies operating in the online classified advertising sector in developing market…”

  • HE’S BUILDING A MEDIA GOLIATH IN MALAYSIA– Tech In Asia.

“The Rev Asia media group is arguably one of Malaysia’s top digital media conglomerates. With 12 sites, it targets the Malay, Chinese, and English-speaking audiences, covering news as well as niche topics, from Malaysia’s electronic dance music scene to how to make the best nasi goreng.”

Request Offer

Capital Insights
The control layer for the electrified home

THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]

Capital Insights
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be  Attracting Big Pharma’s Attention

Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.

Join over 45,000+ sophisticated investors

Join Now